Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06426004 · ClinicalTrials.gov registry record · NA
Addressing Health Disparities in Normal Pressure Hydrocephalus (NPH) in Maryland
A NA study, sponsored by Johns Hopkins Bloomberg School of Public Health.
- Not yet
- Registry status
- NA
- Development phase
- 660
- Enrollment target
NCT06426004: Clinical Trial NA study, sponsored by Johns Hopkins Bloomberg School of Public Health.
NCT06426004 is a NA study that has not yet begun recruiting, run by Johns Hopkins Bloomberg School of Public Health. The registered enrollment target is 660 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (53% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06426004, a NA study, has not yet begun recruiting, sponsored by Johns Hopkins Bloomberg School of Public Health.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 660 participants
- Enrollment target
Study Summary
The study aims to estimate Normal Pressure Hydrocephalus (NPH) prevalence and evaluate health equity gaps in Baltimore and Maryland based on zip codes and race, with a focus on the Black community. Interventions will include educational elements about NPH and three layers targeting patients, Primary Care Providers, and community health workers to enhance care access. Short-term outcomes will measure referrals to specialists, while long-term outcomes will assess healthcare utilization. The study aims to identify and reduce racial disparities in NPH care access, informing intervention strategies for NPH and other surgical areas.
Primary Outcome
number of referrals for suspicion of NPH to neurologists or neurosurgeons
Interventions
- OTHER patients will receive NPH education
- OTHER primary care physicians (PCPs) will receive professional NPH education
- OTHER A community health worker will assist PCP
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 660 participants |
| Start Date | 2027-08-01 |
| Est. Completion | 2032-03-30 |
| Phase | NA |
What is known before NCT06426004 opens enrollment
NCT06426004 is an interventional study that assigns participants to a tested intervention. The registered 660 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (53% lower).
The record links to 0 conditions, and to 3 interventions - of which patients will receive NPH education is the first listed.
NCT06426004 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06426004 about?
NCT06426004 is a clinical study titled "Addressing Health Disparities in Normal Pressure Hydrocephalus (NPH) in Maryland". The study aims to estimate Normal Pressure Hydrocephalus (NPH) prevalence and evaluate health equity gaps in Baltimore and Maryland based on zip codes and race, with a focus on the Black community. Interventions will include educational elements about NPH and three layers targeting patients, Primary...
What is the current status of trial NCT06426004?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 660 participants. The study started on 2027-08-01. Estimated completion is 2032-03-30.
What interventions are being tested in trial NCT06426004?
The interventions under investigation include: patients will receive NPH education (OTHER), primary care physicians (PCPs) will receive professional NPH education (OTHER), A community health worker will assist PCP (OTHER).
Who is sponsoring clinical trial NCT06426004?
This trial is sponsored by Johns Hopkins Bloomberg School of Public Health, which has 187 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06426004's enrollment target sits among peer trials
660 155th of 2000 higher than 1,845 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01185132 · 660 participants · Phase 3
Intensity Modulated Radiotherapy (IMRT) vs. 3D-conformal Accelerated Partial Breast Irradiation (APBI) for Early Stage Breast Cancer After Lumpectomy
- NCT03346694 · 660 participants · NA
Reducing Surgical Site Infection Rates Using an Alternative Sternal Dressing
- NCT05407636 · 660 participants · Phase 3
Pivotal 2 Study of RGX-314 Gene Therapy in Participants With nAMD
- NCT05470205 · 660 participants · Phase 3
Noninvasive Subharmonic Aided Pressure Estimation of Portal Hypertension; Renewal
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI